1. Home
  2. PTGX vs MRCY Comparison

PTGX vs MRCY Comparison

Compare PTGX & MRCY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PTGX
  • MRCY
  • Stock Information
  • Founded
  • PTGX 2006
  • MRCY 1981
  • Country
  • PTGX United States
  • MRCY United States
  • Employees
  • PTGX 130
  • MRCY N/A
  • Industry
  • PTGX Biotechnology: Pharmaceutical Preparations
  • MRCY
  • Sector
  • PTGX Health Care
  • MRCY
  • Exchange
  • PTGX Nasdaq
  • MRCY Nasdaq
  • Market Cap
  • PTGX 5.0B
  • MRCY 4.6B
  • IPO Year
  • PTGX 2016
  • MRCY 1998
  • Fundamental
  • Price
  • PTGX $79.54
  • MRCY $74.67
  • Analyst Decision
  • PTGX Strong Buy
  • MRCY Buy
  • Analyst Count
  • PTGX 9
  • MRCY 8
  • Target Price
  • PTGX $86.22
  • MRCY $72.13
  • AVG Volume (30 Days)
  • PTGX 1.3M
  • MRCY 610.7K
  • Earning Date
  • PTGX 11-06-2025
  • MRCY 11-04-2025
  • Dividend Yield
  • PTGX N/A
  • MRCY N/A
  • EPS Growth
  • PTGX N/A
  • MRCY N/A
  • EPS
  • PTGX 0.72
  • MRCY N/A
  • Revenue
  • PTGX $209,217,000.00
  • MRCY $932,798,000.00
  • Revenue This Year
  • PTGX N/A
  • MRCY $6.17
  • Revenue Next Year
  • PTGX $140.23
  • MRCY $8.23
  • P/E Ratio
  • PTGX $110.77
  • MRCY N/A
  • Revenue Growth
  • PTGX N/A
  • MRCY 8.63
  • 52 Week Low
  • PTGX $33.31
  • MRCY $37.28
  • 52 Week High
  • PTGX $93.25
  • MRCY $85.33
  • Technical
  • Relative Strength Index (RSI)
  • PTGX 62.21
  • MRCY 45.11
  • Support Level
  • PTGX $75.44
  • MRCY $74.07
  • Resistance Level
  • PTGX $80.43
  • MRCY $79.92
  • Average True Range (ATR)
  • PTGX 2.61
  • MRCY 2.78
  • MACD
  • PTGX -0.23
  • MRCY -0.56
  • Stochastic Oscillator
  • PTGX 89.38
  • MRCY 29.64

About PTGX Protagonist Therapeutics Inc.

Protagonist Therapeutics Inc is a clinical-stage biopharmaceutical company having a proprietary technology platform that enables the discovery and development of novel constrained peptide-based drug candidates to address medical needs. Its pipeline products include Rusfertide (PTG-300) and JNJ-2113.

About MRCY Mercury Systems Inc

Mercury Systems Inc is a commercial technology company serving the aerospace and defense industry. The company envisions, creates, and delivers secure open architecture solutions powering a broad range of mission-critical applications in challenging and demanding environments. Its Mercury Processing Platform spans the full breadth of signal processing from radio frequency front end to the human-machine interface to convert meaningful data, gathered in remote and hostile environments, into critical decisions. The company manufactures components, products, modules, and subsystems and sells to defense prime contractors, the U.S. government, original equipment manufacturers, and commercial aerospace companies. Geographically, it derives maximum revenue from the United States.

Share on Social Networks: